PHARMABIDIOL
DEAD

Serial Number

87083307

Owner

Nic Quiles III

Attorney

Eduardo Drake

Filing Date

Jun 24, 2016

Add to watchlist:

No watchlists yet
View on USPTO

PHARMABIDIOL Trademark

Serial Number: 87083307

PHARMABIDIOL is a trademark filed by Nic Quiles III on June 24, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Nic Quiles III (14 trademarks)

2548 North Holton Street
Milwaukee, WI 53212

Entity Type: 01

Trademark Details

Filing Date

June 24, 2016

Registration Date

Not Registered

Published for Opposition

May 23, 2017

Goods & Services

Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treating inflammation, nausea, convulsions, cancer, anxiety, depression; Nutraceuticals for use as a dietary supplement for treating symptoms of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Nutraceuticals for use as a dietary supplement for treating symptoms of Crohns disease, multiple sclerosis, insomnia; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Anti-epileptic pharmaceutical preparations; Dietary and nutritional supplements containing cannabis derivatives, namely, cannabidiol (CBD) oil; Dietary supplements also containing cannabis derivatives, namely, cannabidiol (CBD) oil; Digestives for pharmaceutical purposes; Medicated skin care preparations; Medicated oils containing cannabis derivatives, namely, cannabidiol (CBD) oil; Nutritional food additives for medical purposes in the nature of natural food extracts derived from cannabis, namely, cannabidiol (CBD) oil; Therapeutic pharmaceutical for the treatment of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Therapeutic pharmaceutical for the treatment of inflammation, nausea, convulsions, cancer, anxiety, depression; Therapeutic pharmaceutical for the treatment of Crohns disease, multiple sclerosis, and insomnia

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 20, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 19, 2018 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 18, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 23, 2017 NPUB
PUBLISHED FOR OPPOSITION
May 23, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 3, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 7, 2017 TROA
UNDELIVERABLE MAIL - COURTESY COPY MAILED
Oct 17, 2016 UNDC
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 7, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 7, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 7, 2016 CNRT
ASSIGNED TO EXAMINER
Oct 4, 2016 DOCK
ASSIGNED TO EXAMINER
Oct 1, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 29, 2016 NWOS
NEW APPLICATION ENTERED
Jun 28, 2016 NWAP